STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in treatments for hematologic diseases, has announced its participation in two upcoming investor conferences. The company will present at the Stifel 2024 Healthcare Conference on Tuesday, November 19th at 8:35 a.m. ET, and the Jefferies London Healthcare Conference on Thursday, November 21st at 9:30 a.m. GMT. Live webcasts will be accessible through the company's investor relations website, with archived replays available post-events.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

WATERTOWN, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at two upcoming investor conferences:

  • Stifel 2024 Healthcare Conference on Tuesday, November 19th at 8:35 a.m. ET.
  • Jefferies London Healthcare Conference on Thursday, November 21st at 9:30 a.m. GMT.

A live webcast of the presentations will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com


FAQ

When will Disc Medicine (IRON) present at the Stifel 2024 Healthcare Conference?

Disc Medicine will present at the Stifel 2024 Healthcare Conference on Tuesday, November 19th at 8:35 a.m. ET.

What time is Disc Medicine's (IRON) presentation at the Jefferies London Healthcare Conference?

Disc Medicine will present at the Jefferies London Healthcare Conference on Thursday, November 21st at 9:30 a.m. GMT.

How can investors watch Disc Medicine's (IRON) conference presentations?

Investors can watch the live webcasts through Disc Medicine's investor relations website at ir.discmedicine.com, with archived replays available after the events.

Which investor conferences is Disc Medicine (IRON) attending in November 2024?

Disc Medicine is attending the Stifel 2024 Healthcare Conference and the Jefferies London Healthcare Conference in November 2024.
Disc Medicine Inc

NASDAQ:IRON

IRON Rankings

IRON Latest News

IRON Latest SEC Filings

IRON Stock Data

3.52B
31.55M
10.64%
101.82%
6.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
WATERTOWN